Pneumococcal 15-Valent Conjugate Vaccine Approved for Pediatric Use
For children, Vaxneuvance is administered as a 4-dose series at 2, 4, 6 and 12 through 15 months of age (and at least 2 months after the 3rd dose).
Immunization
Vaccination Strategies to Keep Children With Special Needs Healthy
Children with physical disabilities, neurologic and neurodevelopmental disorders, and autism are at higher risk for vaccine-preventable illnesses.
FDA Approves Additional Option for Measles, Mumps and Rubella Vaccination
Priorix is administered as a 2-dose series (each dose is approximately 0.5mL) via subcutaneous injection.
Pfizer-BioNTech COVID-19 Vaccine Elicits Strong Immune Response in Kids Under 5 After Third Dose
The trial included 1678 children who received a third dose of the 3µg formulation at least 2 months after the second dose of a 2-dose series at a time when Omicron was the predominant variant.
Pfizer-BioNTech COVID-19 Vaccine Booster Dose Authorized for 5 to 11 Year-Olds
The Pfizer-BioNTech COVID-19 vaccine can be administered as a single booster dose to individuals 5 to 11 years of age at least 5 months after completion of the primary series.
Moderna Submits Request for Emergency Use of COVID-19 Vaccine for Young Children
The KidCOVE study included children 6 months to less than 6 years of age who received either two 25mcg doses of mRNA-1273 or placebo, separated by 28 days.
Has the COVID-19 Pandemic Disrupted Routine Immunization Services?
As the medical field shifted its priorities to treating COVID-19 at the start of the pandemic, routine immunization was one of the many medical fields to experience disruption. What was the scope of this disruption and what are possible ways to address it?
Universal Hepatitis B Vaccination Recommended for Adults Aged 19 to 59 Years
CDC updates hepatitis B vaccination recommendation for adults
Second Booster Dose Authorized to Up Protection Against COVID-19 for Certain People
The Emergency Use Authorization was based on safety and immunogenicity data provided to the Agency.
Moderna COVID-19 Vaccine Shows Robust Antibody Responses in Young Children
The KidCOVE study is currently evaluating the immunogenicity, safety, and tolerability of the mRNA-1273 vaccine in healthy children.
- Loading...
Loading...
Next post in Pediatrics Information Center
Loading... 
Loading...